Anhui Anke Biotechnology (Group) Co., Ltd. (SZSE:300009) agreed to acquire 11.31% stake in Anhui Xinhuakun Biological Engineering Co., Ltd. from a group of shareholders for CNY 10.3 million on December 12, 2023. As of June 30, 2023, Anhui Xinhuakun Biological Engineering Co., Ltd. generated, total assets of CNY 92.6281 million and net assets of 89.7 million. The transaction is approved by board of directors of Anhui Anke Biotechnology (Group) Co., Ltd.